20 results
8-K
EX-1.1
ATXS
Astria Therapeutics Inc
4 Mar 24
Entry into a Material Definitive Agreement
5:22pm
8-K
EX-1.1
ATXS
Astria Therapeutics Inc
31 Jan 24
Astria Therapeutics Announces Pricing of $125 Million Underwritten Offering
9:00am
8-K
EX-1.1
ATXS
Astria Therapeutics Inc
12 Oct 23
Astria Therapeutics Announces Pricing of $64 Million Underwritten Offering
5:04pm
SC 13G/A
EX-1
Altium Capital Management LP
14 Feb 23
Astria Therapeutics / Altium Capital Management ownership change
3:59pm
8-K
EX-1.1
ATXS
Astria Therapeutics Inc
15 Dec 22
Astria Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock
5:18pm
8-K
EX-1.1
y038wmq ru9h
30 Jun 21
Entry into a Material Definitive Agreement
4:25pm
SC 13G/A
EX-1
kse6y
16 Feb 21
CATABASIS PHARMACEUTICALS / Altium Capital Management ownership change
7:33am
8-K
EX-1.1
6m4rybld46jdnb
30 Jan 20
Catabasis Pharmaceuticals Announces Pricing of $23 Million Underwritten Public Offering
4:03pm
8-K
EX-1.1
938iw2vg9uj9zmgpuy
6 Feb 19
Catabasis Pharmaceuticals Announces Pricing of $20 Million Underwritten Public Offering
4:13pm
8-K
EX-1.1
f0e00utcb7h9ntyt
13 Nov 18
Entry into a Material Definitive Agreement
8:48am
8-K
EX-1.1
kyo m28n5l0nrmb2dr1
20 Jun 18
Catabasis Pharmaceuticals Announces Pricing of $42 Million Underwritten Public Offering
9:13am
SC 13G/A
EX-1
o85cm7bnav5ig8urbp
14 Feb 18
Catabasis Pharmaceuticals Inc
12:00am
8-K
EX-1.1
nqpg03xc snjcpyy6caj
13 Oct 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
mfuo1z3mx7rb7uk
23 Sep 16
Catabasis Pharmaceuticals Announces Pricing of $10 Million Offering of Common Stock
12:00am
8-K
EX-1.1
mzpx1oli6qs
11 Aug 16
Entry into a Material Definitive Agreement
12:00am
SC 13G/A
EX-1
g2dgh
12 Feb 16
Catabasis Pharmaceuticals Inc
12:00am
SC 13G
EX-1
c7hi c2ka
6 Jul 15
Catabasis Pharmaceuticals Inc
12:00am
- Prev
- 1
- Next